Mural Oncology plc
MURA
$2.09
-$0.01-0.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.71% | -15.79% | -7.13% | 53.09% | 58.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.63% | -25.52% | -29.54% | -13.06% | -7.95% |
| Operating Income | 21.63% | 25.52% | 29.54% | 13.06% | 7.95% |
| Income Before Tax | 11.54% | 28.19% | 34.19% | 17.98% | 11.55% |
| Income Tax Expenses | -- | -- | -- | -82.68% | -10.77% |
| Earnings from Continuing Operations | 15.09% | 31.87% | 38.05% | 21.74% | 11.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.09% | 31.87% | 38.05% | 21.74% | 11.52% |
| EBIT | 21.63% | 25.52% | 29.54% | 13.06% | 7.95% |
| EBITDA | 22.39% | 26.27% | 30.42% | 13.67% | 8.62% |
| EPS Basic | 17.06% | 33.24% | 39.03% | 22.38% | 11.84% |
| Normalized Basic EPS | 23.77% | 29.63% | 35.23% | 18.66% | 11.89% |
| EPS Diluted | 17.06% | 33.24% | 39.03% | 22.38% | 11.84% |
| Normalized Diluted EPS | 23.77% | 29.63% | 35.23% | 18.66% | 11.89% |
| Average Basic Shares Outstanding | 2.15% | 1.99% | 1.58% | 1.02% | 0.51% |
| Average Diluted Shares Outstanding | 2.15% | 1.99% | 1.58% | 1.02% | 0.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |